Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid LiposarcomaMarcel Trautmann, Jasmin Menzel, Christian Bertling, et al.
British Journal of Haematology|July 31, 2025
Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT studyMaximilian Schönung, Silvia Rathmann, Senthilkumar Ramamoorthy, et al.
Oncoimmunology|February 16, 2017
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-GSareetha Kailayangiri, Bianca Altvater, Christian Spurny, et al.
Molecular Oncology|December 8, 2019
Focal adhesion kinase confers pro-migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcomaKonrad Steinestel, Marcel Trautmann, Esther-Pia Jansen, et al.
Cancers|October 13, 2021
Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription FactorsBettina Kotter, Fabian Engert, Winfried Krueger, et al.
Frontiers in Immunology|November 22, 2021
Generation of an NFκB-Driven Alpharetroviral "All-in-One" Vector Construct as a Potent Tool for CAR NK Cell TherapyLoreen Sophie Rudek, Katharina Zimmermann, Melanie Galla, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 13, 2022
SS18-SSX drives CREB activation in synovial sarcomaMagdalene Cyra, Miriam Schulte, Ruth Berthold, et al.
Cancers|February 12, 2020
Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible CytokinesKatharina Zimmermann, Johannes Kuehle, Anna Christina Dragon, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
Cancer Gene Therapy|June 30, 2023
CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering processBianca Altvater, Sareetha Kailayangiri, Christian Spurny, et al.
Pageof 15